Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133585) titled 'Effects of Alpha-Ketoglutarate (AKG) on Human Anti-Aging Biomarkers and Functions: A Randomized Controlled Trial' on Sept. 29.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First People's Hospital of Kunshan
Condition:
Aging
Intervention:
Test substance group:Oral AKG capsules, 2 times daily, 2 capsules each time (0.375g per capsule), continuously for 14 weeks
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-01
Target Sample Size: Test substance group:40;Placebo group:40;
Countries of Recruitment:
China
To know more, visit https://www.c...